We are delighted to announce that our SARS-CoV-2 Antigen Self-Testing Rapid Kits for Nasal Swabs and Oral Fluid has successfully been approved by the Italian Ministry of Health. This approval from another highly recognized and trusted national medical regulatory body is a testament to the quality of our COVID-19 rapid tests. This also means that [...]
We are delighted to announce that our SARS-CoV-2 Antigen Self-Testing Rapid Kits for Nasal Swabs and Oral Fluid has successfully passed the approval from Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). This approval from the highly recognized and trusted medical regulatory body is a testament to the quality of our COVID-19 rapid tests. This also means [...]
Following regulatory approval, we are pleased to add 2 COVID-19 Over the Counter Tests to our product offering. If you would like to act as our distributor for these tests, please contact us now to receive your samples. SARS-CoV-2 Antigen Rapid Test (Nasal Swab) – Cat. No D-COVAGSTN7 SARS-CoV-2 Antigen Rapid Test (Oral Fluid) – [...]
2022 has been a year of change for many of us, with the effects of COVID continuing to shape all our lives, new ways of working have been required and fresh challenges are faced with material shortages, delivery delays and freight costs skyrocketing…. Rapid Labs has also had a number of significant changes this year, [...]
We’re pleased to share our new medical brochure for 2022. Over the past year we have added new products to our existing ranges, including dozens of new drugs of abuse tests and rapid lateral flow tests, as well as our new range of bacterial typing anti-sera and the virusPHIX molecular transport medium for virus inactivation [...]
As another year draws to an end, we would like to take the opportunity to thank all of our customers for their continued support over the past year and wish everyone a very merry Christmas. Our offices will be closed from the 24th December and will reopen on the 4th January. Any orders placed after [...]
QCMD will use the universal biological sample stabilisation virusPHIX-P9™ as the matrix within its forthcoming SARS-CoV-2 antigen EQA pilot scheme. Studies have proven that virusPHIX-P9™ is both capable of inactivating SARS-CoV-2 as well as stabilizing clinical samples at ambient temperatures. Extensive testing at QCMD has shown that virusPHIX-P9™ is compatible with a variety of SARS-CoV-2 [...]
RNAssist (Cambridge UK) and Rapid Labs Ltd (Colchester, UK) have launched the virusPHIX™ range of virus inactivating and RNA stabilising transport media, following successful SARS-CoV-2 inactivation. virusPHIX™ is a novel RNA stabiliser and virus inactivation medium based on technology developed by RNAssist Limited (Cambridge, UK). It has been shown to stabilise viral RNA for up [...]
We would like to wish all our customers a very merry Christmas and a happy new year. Please note that our offices close on Thursday 24th December and will reopen on Monday 4th January. After what has been a tough year for everyone, we look forward to a bright and healthy 2021.
Rapid Labs have been awarded an £80,000 grant from Tendring District Council to increase production capacity at their biomedical facility in Little Bentley. The grant has contributed towards the cost of a new ISO 8 clean room facility, which is primarily being used for the manufacture and development of a novel RNA stabiliser and virus [...]